Stay Informed on Key Developments

Investor News and Updates

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

221 - 230of 392 News

July 08, 2020

Bayer remains committed to Roundup™ settlement

July 08, 2020

Bayer remains committed to Roundup™ settlement

July 08, 2020

Bayer remains committed to Roundup™ settlement

July 01, 2020

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer issues new senior bonds with a volume of 6 billion euros

June 24, 2020

Bayer announces agreements to resolve major legacy Monsanto litigation

June 19, 2020

Women empowerment in times of COVID-19

Bayer supports "The Challenge Initiative" of Johns Hopkins Bloomberg School of Public Health with 10 million USD

June 17, 2020

Bayer to Provide Crop Relief to Two Million Smallholder Farmers Impacted by COVID-19

June 15, 2020

Not intended for U.S. and UK Media

Bayer extends clinical development program for finerenone with Phase III study in patients with heart failure and preserved ejection fraction

June 05, 2020

Not intended for U.S. and UK Media

Bayer submits vericiguat for marketing authorization in the EU and Japan for the treatment of chronic heart failure

May 29, 2020

Not intended for U.S. and UK Media - American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program):

Efficacy of Vitrakvi™ further established with continued high response rates and durable response in updated analyses in adult patients and quality of life data in adult and pediatric patients

Inform Yourself on Special Topics

Investor News and Updates

Control Weeds, Not Farming

Everything You Need to Know About Glyphosate

Managing Glyphosate Litigation

Managing and Mitigating PCB Litigation Risk